AMYLYX PHARMACEUTICALS INC
Public company snapshot, recent ticker-linked headlines, and a path into evidence-backed AI research.
Latest price
$28.86
+0.63%
Yahoo Finance · 10/30/2026
One-year price history
Adjusted daily closes · 252 observations · as of Oct 30, 2026
1 month
+2.8%
3 months
+43.1%
6 months
+80.3%
1 year
+105.4%
Year to date
+138.9%
52-week range
$11.38 – $39.66
Fundamental snapshot
Latest reported period: Jun 30, 2026
Market cap
$3.22B
P/E
-21.1
P/B
13.4
P/S
—
Revenue
$0
Net income
-$152.09M
Diluted EPS
-1.41
Gross margin
—
Net margin
—
Return on equity
-52.90%
Total debt
$5.26M
Cash
$50.31M
Free cash flow
-$126.72M
Latest eight reported quarters
Reported quarterly values, newest first
| Period | Revenue | Net income | Gross margin | Net margin | Free cash flow |
|---|---|---|---|---|---|
| Jun 30, 2026 | $0 | -$43.42M | — | — | -$31.45M |
| Mar 31, 2026 | $0 | -$41.28M | — | — | -$36.88M |
| Dec 31, 2025 | $0 | -$33M | — | — | -$27.99M |
| Sep 30, 2025 | $0 | -$34.39M | — | — | -$30.39M |
| Jun 30, 2025 | $0 | -$41.44M | — | — | -$25.27M |
| Mar 31, 2025 | $0 | -$35.91M | — | — | -$39.84M |
| Dec 31, 2024 | -$665K | -$37.55M | 100.00% | 5646.00% | -$59.03M |
| Sep 30, 2024 | $416K | -$72.7M | -94.50% | -17476.90% | -$41.55M |
Reported figures can reflect company reporting conventions, restatements, or sector-specific accounting. Verify against filings before relying on a valuation comparison.
Recent AMLX news
All market newsNo ticker-linked stories are in the current archive.